ROYALTY PHARMA
Live / Registered — Registered (as of 16 Nov 2021)
What this means for you
Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90178440
- Registration number
- 6558516
- Mark type
- Stylized text
- Filed
- 14 Sept 2020
- Published for opposition
- 31 Aug 2021
- Registered
- 16 Nov 2021
- Attorney of record
- David C. Lee
Goods and services
- Class 035 — Advertising and business services: Acquisition and merger consultation, namely, identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment
- Class 036 — Insurance and financial services: Financial services, namely, capital and fund investment services; investment management and investment advisory services; identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment, namely, financial analysis in the nature of financial modelling of the future value of biopharmaceutical royalties and complex structured financing
Owner
- RP Management, LLC, New York, NY, US
- RP Management, LLC, New York, NY, US
- RP Management, LLC, New York, NY, US
Prosecution history
- 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 31 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Aug 2021 — PUBLISHED FOR OPPOSITION
- 11 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jul 2021 — EXAMINER'S AMENDMENT ENTERED
- 14 Jul 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Jul 2021 — EXAMINERS AMENDMENT E-MAILED
- 14 Jul 2021 — EXAMINERS AMENDMENT -WRITTEN
- 20 May 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 May 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 May 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Mar 2021 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 04 Feb 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Feb 2021 — NON-FINAL ACTION E-MAILED